SMAD SHUTTLING · TGF-beta signal transduction:mechanisms of Smad2/3 nucleocytoplasmic transport
FP6 — Marie Curie Actions (Human Resources and Mobility)
- Duration
- 2006-06-01 → 2008-05-31
- EU contribution
- €159,613
- Participants
- 1
- Scheme
- IIF
Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.
Results in brief
Final Activity Report Summary - SMAD SHUTTLING (TGF-beta signal transduction:mechanisms of smad2/3 nucleocytoplasmic transport)
TGF-beta is a multipotent growth factor involved in embryogenesis and tissue homeostasis. TGF-beta-type ligands signal through Smad proteins, a subset of which are phosphorylated in response to TGF-beta, which creates the interaction interface enabling Smads to form complexes that then accumulate in the nucleus, where they are directly involved in target gene expression. Perturbation of this pathway has severe implications on embryogenesis and can cause cancer in adult organisms. Nuclear Smad accumulation is a key feature of the pathway, and we have aimed to elucidate quantitative aspects, in particular how the intensity and duration of the active signal is relayed into the nucleus. To this end, we have created human cell lines expressing Smads fused to Green fluorescent protein (GFP), allowing as to study the kinetics of Smad nucleocytoplasmic dynamics in vivo by fluorescence perturbation approaches such as photobleaching and photoactivation on a laser scanning confocal microscope. We have found that nuclear accumulation of Smads in response to TGF-beta is not static, but is dynamically maintained by continuous Smad phosphorylation in the cytoplasm by active receptors and dephosphorylation in the nucleus. These two processes are coupled by Smad nucleocytoplasmic cycling. Importantly, we find that nuclear accumulation is caused by a pronounced export deficiency of complexed Smad, superseding earlier theories of a release of Smads from cytoplasmic retention in response to TGF-beta as the driving force of nuclear accumulation. The quantitative information obtained by fluorescence perturbation was used together with other time course data to establish a mathematical model of the nucleocytoplasmic dynamics of Smads. We were able to recreate the behaviour of the biological system using a system of ordinary differential equations. The model provided novel insights into mechanistic details of the biological system. It became now clear that nuclear retention of complexed Smads is not sufficient to explain the observed accumulation kinetics, but that Smad complexes also need to be imported into the nucleus faster than monomeric Smads. Most importantly, the model demonstrates convincingly that Smad nucleocytoplasmic dynamics are able to faithfully translate intensity and duration of the extracellular signal into a corresponding amount of nuclear Smad complexes, and hence appropriate target gene expression. We thus explain how the quantitative features of the signal are transmitted into the nucleus, which is a key insight of huge relevance for the understanding of how morphogenic gradients are interpreted during embryonic development. The second part of the work carried out during the funding period was the identification of PPP2R2D, a regulatory B-subunit of the protein phosphatase PP2A, as a novel factor limiting the TGF-beta response to signal intensities above a critical threshold. We also identified the closely related B-subunit PPP2R2A as a protein protecting the type I receptors ALK4 and ALK5 from lysosomal degradation, thus augmenting TGF-beta signalling. These findings are of particular interest, first, because manipulation of the levels of these proteins has extreme phenotypic effects on early Xenopus development, second, because we demonstrate for the first time specific, non-redundant functions of PPP2R2A and PPP2R2D, and, third, because parts of these functions are conserved from fly to man.
Data: CORDIS, © European Union
Project objective
TGF-ß related growth factors signal through Smad proteins that transfer the signal from the receptor directly into the nucleus. The receptor-regulated Smads (R-Smads) Smad2 and SmadS arephosphorylated by the receptor kinase and form complexes with Smad4 that accumulate in the nucleus, where they participate in the regulation of gene transcription. Like Smad4, Smad2 and SmadS exhibit nucleocytoplasmic shuttling irrespective of the presence or absence of a signal.This project aims at answering two clearly define d questions. Firstly, how does phosphorylation of R-Smadstrigger nuclear accumulation despite their constitutive shuttling properties? And secondly, which import and export receptors (karyopherins) or other regulatory proteins are involved in these transport processes? To answer these questions, a set of powerful experimental approaches will be employed. In the first phase, a novel GFP photo-activation approach will allow detailed studies of nucleocytoplasmic transport kinetics in real time in vivo. I will be able to dissect import from export and study both processes independently. In the second phase, I will take advantage of an in vitro import assay using permeabilised cells depleted of cytoplasm to directly compare the import characteristics of recombinant full length phosphorylated, recombinant unphosphorylated Smad2 as well as of active PhosphoSmad2/Smad4 complexes under different conditions. In a more wide-ranging approach, novel players involved in R-Smad import and export will be identified by a screen using a n siRNA library targeting over 8000 human mRNAs.A quantitative in vivo export assay will be used to further characterise the effect of knock down of candidate proteins involved in R-Smad export. The project involves a plethora of novel methods, including cut ting edge microscopy and employment of functional genomics using an RNAi library.
Original text from CORDIS.
Participants
- CANCER RESEARCH UK LONDON RESEARCH INSTITUTE · LONDONCoordinatorCity levelUnited Kingdom
Links
Data: CORDIS, © European Union
